Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae

Keyphrases

• Cystic Fibrosis 100%
• β-lactamase 100%
• Haemophilus Influenzae 100%
• Chronic Obstructive Pulmonary Disease 100%
• New Antibiotics 100%
• Lower Respiratory Tract Infection 100%
• Resistant Strains 100%
• Ampicillin 100%
• Ampicillin Resistance 100%
• H. Influenzae 100%
• β-lactamase Inhibitor 50%
• Diarrhea 50%
• Antibiotics 50%
• Inpatient Treatment 50%
• Esters 50%
• Adverse Reactions 50%
• Lower Respiratory Tract 50%
• Oral Use 50%
• Sulbactam 50%
• Compound Agent 50%
• H. Influenzae Infection 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Lower Respiratory Tract Infection 100%
• Haemophilus influenzae 100%
• Sultamicillin 100%
• Antimicrobial Agent 100%
• Ampicillin 80%
• Cystic Fibrosis 40%
• Beta Lactamase 40%
• Chronic Obstructive Lung Disease 40%
• Beta Lactamase Inhibitor 20%
• Infection 20%
• Antibiotics 20%
• Adverse Drug Reaction 20%
• Diarrhea 20%
• Respiratory Tract 20%
• Sulbactam 20%
• Bacterium 20%